Emerging evidence on Omicron (B.1.1.529) SARS‐CoV‐2 variant-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Emerging evidence on Omicron (B.1.1.529) SARS‐CoV‐2 variant

Published:2022-02-03 Issue:5 Volume:94 Page:1876-1885
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Sharma Vineet¹^ORCID,Rai Himanshu²^ORCID,Gautam Dev N. S.¹^ORCID,Prajapati Pradeep K.³^ORCID,Sharma Rohit¹^ORCID

Affiliation:

1. Department of Rasa Shastra and Bhaishajya Kalpana, Faculty of Ayurveda, Institute of Medical Sciences Banaras Hindu University Varanasi India

2. DST‐Centre for Interdisciplinary Mathematical Sciences, Institute of Science Banaras Hindu University Varanasi India

3. Department of Rasa Shastra and Bhaishajya Kalpana All India Institute of Ayurveda New Delhi India

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27626

Reference92 articles.

1. Update on Omicron. WHO. Nov 28 2021. Accessed January 18 2022.https://www.who.int/news/item/28-11-2021-update-on-omicron

2. SARS-CoV-2 B.1.1.529 (Omicron) Variant — United States, December 1–8, 2021

3. Epidemiological characterisation of the first 785 SARS-CoV-2 Omicron variant cases in Denmark, December 2021

4. International risk of SARS‐CoV‐2 Omicron variant importations originating in South Africa;Bai Y;medRxiv,2021

5. Neutralization of SARS‐CoV‐2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients;Lu L;medRxiv,2021

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Visual analysis on ferroptosis and its cross-talk to coronavirus disease 2019 (COVID-19);Heliyon;2024-09

2. Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategies;Heliyon;2024-05

3. Revealing biomarkers and major pathways between SARS-CoV-2 and SARS-like viruses using transcriptomics analysis;Human Gene;2024-05

4. Modelling the impact of hybrid immunity on future COVID-19 epidemic waves;BMC Infectious Diseases;2024-04-16

5. Paradigm of immune dysregulation in coronavirus disease-2019 infection;Exploration of Immunology;2024-01-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3